There’s just one week left until Xconomy’s latest biotech event, “San Francisco Biotech: The Next Generation.” Don’t let the clock run out while you can still save some cash on a ticket.
Next Wednesday, Dec. 5, company founders and visionary scientists will share how they are pursuing new ideas and breaking biotech boundaries. Don’t wait to register—our Procrastinator’s Special ends soon and it’s your last chance at a discount.
Speakers include:
- Alison Moore, Chief Technical Officer, Allogene Therapeutics
- David Chang, President, CEO, & Co-founder, Allogene Therapeutics
- Wendell Lim, Director, UCSF Center for Systems & Synthetic Biology
- Nancy Yu, CEO & Co-founder, RDMD
- Onno Faber, Founder, Chairman & Head of Product, RDMD
- Tristen Moors, Executive Director of Clinical Operations, Modis Therapeutics
- Casey Lynch, CEO & Co-founder, Cortexyme
- David Dolby, Managing Director, Dolby Family Ventures
- Tiffany Reiter, Principal, Fish & Richardson
You can find the full agenda for the evening here.
This is an event you won’t want to miss, so grab your ticket today. See you there!